Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: clinical trial startup

IND Application Requirements under FDA Guidelines: A Step-by-Step Regulatory Overview

Posted on May 11, 2025 digi By digi

IND Application Requirements under FDA Guidelines: A Step-by-Step Regulatory Overview Preparing an IND Application: Key Requirements According to FDA Guidelines Before any investigational drug can be administered to humans in the United States, the sponsor must submit an Investigational New Drug (IND) application to the USFDA. This essential regulatory step ensures that patients are protected…

Read More “IND Application Requirements under FDA Guidelines: A Step-by-Step Regulatory Overview” »

Regulatory Guidelines, U.S. FDA Regulations

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development
  • Cardiac Safety in Phase 1: QTc and Intensive ECG Monitoring
  • Endpoint Hierarchy Planning and Sensitivity Analyses in Phase 3 Trials: Ensuring Statistical Validity and Regulatory Confidence
  • Data Mining for Adverse Drug Reactions in Phase 4 Clinical Trials
  • Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme